Inaddition, the authors demonstrated that cells with such a specific cell surfaceantigen profile could successfully and efficiently grow as tumor xenografts inimmunodeficient mice; the highest capacity to form tumors was observed afterinjection of 200 cells with the ESA+/CD44+/CD24low/lin− phenotype. The gene discussed is CD44; the disease is neoplasm.